McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.
Follow MCK
McKesson Corporation (MCK) Price to free cash flow
As of 16 October 2026, McKesson Corporation (MCK) trades at a price to free cash flow of 19.5×. Over the past ten years it has ranged from 5.2× (February 2021) to 51.5× (March 2025); the current reading is higher than 92% of that period. That is in line with the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2026 | 19.8× | 20.51% |
| FY2025 | 16.4× | (16.73%) |
| FY2024 | 19.7× | 80.44% |
| FY2023 | 10.9× | (8.69%) |
| FY2022 | 12.0× | 48.92% |
| FY2021 | 8.0× | 27.14% |
| FY2020 | 6.3× | (5.82%) |
| FY2019 | 6.7× | (13.19%) |
| FY2018 | 7.7× | (1.42%) |
| FY2017 | 7.8× | (35.12%) |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 14.6× | (26.17%) |
| Mar 2026 | 19.8× | 88.67% |
| Dec 2025 | 10.5× | (34.28%) |
| Sep 2025 | 15.9× | (1.29%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| HKPD Cellyan Biotechnology Co., Ltd compare | n/m |
| ACH Accendra Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | n/m |
| COSM Cosmos Health Inc. compare | n/m |
| CAH Cardinal Health, Inc. compare | 13.2× |
| COR Cencora, Inc. compare | 16.0× |
| HSIC Henry Schein, Inc. compare | 17.2× |
| MCK McKesson Corporation | 19.5× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on MCK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement